Browse studies

Find your next paid study

27,295 recruiting studies available now

Phase 1/2 Study of Dinutuximab/Cyclophosphamide/Topotecan/Sargramostim (GM-CSF) With or Without Iberdomide in Children With Relapsed, Refractory, or Progressive Neuroblastoma Following Prior Chemoimmunotherapy

This phase I/II trial studies the side effects and best dose of iberdomide when given together with chemoimmunotherapy drugs and to see how well it works in tr…

Recurrent GanglioneuroblastomaRecurrent NeuroblastomaRefractory Ganglioneuroblastoma+1 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07437963

Phase 1

A Phase 1B Study of Combination ATR (M1774) and BET Inhibition (ZEN003694) to Exploit ARID1A Loss in Recurrent Ovarian and Endometrial Cancer

This phase Ib trial tests the safety, side effects, and best dose of M1774 when given with ZEN-3694 in treating patients with ovarian and endometrial cancer th…

Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid Adenocarcinoma+6 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

Observational

Digital Screening and Brief Intervention for Perinatal Substance Use in Home Visiting

The goal of this study is to learn about whether digital screening and brief intervention can help address substance use in postpartum mothers who are enrolled…

Substance Use

Estimated

~$10 – $750

Actual pay is set by the research site.

The National Center on Addiction and Substance Abuse at Columbia UniversityNCT06624332

Phase 1

A Phase I/II, First-in-Human, Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Preliminary Efficacy, and Immunogenicity of TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.

The goal of this clinical trial is to evaluate whether TJ102, an investigational antibody-drug conjugate (ADC), can safely and effectively treat patients with …

Ovarian Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Phrontline BiopharmaNCT07778498

Phase 2

Immunogenicity and Safety of Consecutive High-Dose vs. Standard-Dose Influenza Vaccines Administered Over Successive Seasons in Lung Transplant Recipients

This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-…

Immunization; Infection|Transplantation Infection|InfluenzaInfluenza

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT07192458

Validation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) for Adolescents

Vestibular migraine (VM) is the most common cause of episodic dizziness in children and adults. Dizziness, especially in conjunction with other migraine sympto…

Vestibular Migraine

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT07532109

Phase 2

Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer (MAPPER)

This is an exploratory phase II interventional study that initiates standard-of-care anti-estrogen treatment preoperatively for 4-12 weeks (+/- 2 weeks).

Breast Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Medical College of WisconsinNCT06361940

Phase 3

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy

Patients with a bunion will have that repaired and then pain and rescue medicine use will be evaluated.

Postoperative PainBunion

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Cali Pharmaceuticals LLCNCT07490496

Observational

Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing

This 2x2 randomized crossover feasibility study will evaluate the therapeutic value of adding pacing from the left ventricular lead to Left Bundle Branch Area …

Heart FailureSystolic Bundle Branch Block, Left

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Medtronic Cardiac Rhythm and Heart FailureNCT07526896

Phase 1

Open-label Randomized, Three-fold Cross-over, Single-center Interaction Study to Investigate the Influence of Multiple Doses of Acetylsalicylic Acid (ASA) (Aspirin) on the Pharmacodynamics of BAY 3389934 in Healthy Participants.

The study treatment BAY3389934 is under development for people with blood clotting problems that occur due to sepsis. Sepsis is a serious condition that happen…

Drug-drug Interaction

Estimated

~$500 – $11,250

Actual pay is set by the research site.

BayerNCT07652723

Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being

The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or del…

Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related

Estimated

~$10 – $750

Actual pay is set by the research site.

The Cooper Health SystemNCT02749474

Observational

A Prospective Study to Evaluate the Use of the Minder Device to Aid in Developing a Treatment Plan After Inconclusive Prolonged EEG in Patients With Epilepsy

The purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well captur…

EpilepsyEpilepsy (Treatment Refractory)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Epiminder America, Inc.NCT07110337